These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1000491)

  • 21. Kupffer cell stimulation with Corynebacterium parvum reduces some cytochrome P450-dependent activities and diminishes acetaminophen and carbon tetrachloride-induced liver injury in the rat.
    Raiford DS; Thigpen MC
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):36-45. PubMed ID: 7974494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex-related differences in drug-metabolizing enzyme activity of rats in carrageenan-induced inflammation.
    Ishikawa M; Sasaki K; Shiba Y; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Aug; 69(2):229-32. PubMed ID: 2396049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with the quality control testing of C. parvum suspension for clinical trial.
    Knight PA; Lucken RN
    Dev Biol Stand; 1977 Apr 13-15; 38():51-8. PubMed ID: 608544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of microsomal drug hydroxylation in lung and liver of various species.
    Oppelt WW; Zange M; Ross WE; Remmer H
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):43-56. PubMed ID: 5524315
    [No Abstract]   [Full Text] [Related]  

  • 27. Corynebacterium parvum: effects on the biochemistry of mouse serum and liver.
    Green S; Dobrjansky A
    J Natl Cancer Inst; 1979 Aug; 63(2):497-502. PubMed ID: 379402
    [No Abstract]   [Full Text] [Related]  

  • 28. Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria.
    Adlam C; Scott MT
    J Med Microbiol; 1973 Aug; 6(3):261-74. PubMed ID: 4726332
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of vitamin A deficiency on the pulmonary and hepatic drug-metabolizing enzymes in rat.
    Dogra SC; Khanduja KL; Gupta MP; Sharma RR
    Enzyme; 1983; 30(2):99-104. PubMed ID: 6617630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of unilateral pneumonectomy on in vitro drug metabolism by the contralateral lung of rabbits.
    Mimnaugh EG; Siddik ZH; Trush MA; Drew R; Gram TE
    Drug Metab Dispos; 1979; 7(4):208-10. PubMed ID: 39721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice.
    Castro JE
    Eur J Cancer (1965); 1974 Feb; 10(2):115-20. PubMed ID: 4611769
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of Corynebacterium parvum on liver proliferation and regeneration.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Cancer Res; 1979 Apr; 39(4):1361-8. PubMed ID: 421219
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of hydrocortisone on the immune response of mice treated with Corynebacterium parvum.
    Greenberg CS; Dimitrov NV
    Clin Immunol Immunopathol; 1976 Mar; 5(2):264-71. PubMed ID: 776469
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreased hepatic drug demethylation in patients receiving chemo-immunotherapy.
    Lipton A; Hepner GW; White DS; Harvey HA
    Cancer; 1978 May; 41(5):1680-4. PubMed ID: 647621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Corynebacterium parvum and anaesthetics.
    Farquhar D; Loo TL; Reed R; Luna M
    Lancet; 1975 Apr; 1(7912):914. PubMed ID: 47551
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug metabolizing activity in birds: compared activity of liver and duodenum in four species (author's transl)].
    Riviere JL
    Ann Rech Vet; 1979; 10(1):107-11. PubMed ID: 539771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of phenytoin and liver cytochrome P-450 levels in mice after single doses of Corynebacterium parvum [proceedings].
    Mullen PW
    Br J Pharmacol; 1979 Nov; 67(3):470P-472P. PubMed ID: 497584
    [No Abstract]   [Full Text] [Related]  

  • 38. Depression of hepatic biotransformations by chemical immunoadjuvants.
    Giampietri A; Puccetti P; Contessa AR
    J Immunopharmacol; 1981; 3(2):251-64. PubMed ID: 7338632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organ distributions and clearance studies of 99mtechnetium-labeled Corynebacterium parvum in patients with leukemia.
    Toki H; Hersh EM; Gutterman JU; Haynie TP; Glenn H; White RA; Rios A
    Int J Immunopharmacol; 1981; 3(2):141-5. PubMed ID: 7263121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumour effect of corynebacterium parvum. Possible mode of action.
    Baum M; Breese M
    Br J Cancer; 1976 Apr; 33(4):468-73. PubMed ID: 1268035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.